Sort   by:  
 Page size 
UnknownImproving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities.
Not available
S-EPMC8423356 | biostudies-literature
UnknownEnding the HIV epidemic in the USA: an economic modelling study in six cities.
Not available
S-EPMC7338235 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
UnknownAssociation analysis identifies 65 new breast cancer risk loci.
Not available
S-EPMC5798588 | biostudies-literature
UnknownBreast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
Not available
S-EPMC7611105 | biostudies-literature
UnknownMultiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Not available
S-EPMC3670748 | biostudies-literature
UnknownResponses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
Not available
S-EPMC9334931 | biostudies-literature
UnknownEfficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial.
Not available
S-EPMC8700279 | biostudies-literature
UnknownA Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
Not available
S-EPMC7781100 | biostudies-literature
Sort   by:  
 Page size